Q: My understanding that there might be hundreds of companies on the Venture and CSE exchanges involved with the BridgeMark Group. Can you comment it seems both exchanges have almost zero monitoring in terms of investor protection. The news was general downplayed and many of the affected companies named continue to attract investors.
“Based on evidence obtained in respect of the other seven issuers (companies), Staff are concerned that members of the BridgeMark Group also executed the scheme with those issuers,” stated BCSC. The other seven companies include: Kootenay Zinc Corp.; Affinor Growers Inc.; Beleave Inc.; Liht Cannabis Corp. (formerly known as Marapharm Ventures Inc.); PreveCeutical Medical Inc.; Speakeasy Cannabis Club Ltd.; and Abattis Bioceuticals Corp.
To date, BCSC has temporarily banned BridgeMark members from buying or selling shares of the 11 companies. It has also blocked all CSE-listed companies from using the consultant exemption to sell shares to BridgeMark members.
“Based on evidence obtained in respect of the other seven issuers (companies), Staff are concerned that members of the BridgeMark Group also executed the scheme with those issuers,” stated BCSC. The other seven companies include: Kootenay Zinc Corp.; Affinor Growers Inc.; Beleave Inc.; Liht Cannabis Corp. (formerly known as Marapharm Ventures Inc.); PreveCeutical Medical Inc.; Speakeasy Cannabis Club Ltd.; and Abattis Bioceuticals Corp.
To date, BCSC has temporarily banned BridgeMark members from buying or selling shares of the 11 companies. It has also blocked all CSE-listed companies from using the consultant exemption to sell shares to BridgeMark members.